Harbour Investments’s Beam Therapeutics BEAM Stock Holding History

Harbour Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.7K	Buy	691 +109	+19%	+$3.29K	﹤0.01%	2859
2026 Q1	$13.9K	Buy	582 +419	+257%	+$11.6K	﹤0.01%	3092
2025 Q4	$4.52K	Buy	+163	New	+$4.16K	﹤0.01%	3051
2021 Q4	$8K	Sell	100 -50	-33%	-$4.28K	﹤0.01%	1998
2021 Q3	$13K	Hold	150	–	–	﹤0.01%	2515
2021 Q2	$19K	Buy	150 +102	+213%	+$8.13K	﹤0.01%	2365
2021 Q1	$4K	Buy	+48	New	+$4.57K	﹤0.01%	2964

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Harbour Investments's BEAM Position: Q2 2026 in Review

Harbour Investments increased its Beam Therapeutics (BEAM) stake by 19% in Q2 2026, buying an estimated $3.29K and bringing the position to 691 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

Harbour Investments first reported a position in BEAM in Q1 2021 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Harbour Investments held 691 shares of Beam Therapeutics worth $23.7K as of Q2 2026.
Harbour Investments bought 109 Beam Therapeutics shares in Q2 2026, an estimated $3.29K.
Beam Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2859 holding.
Harbour Investments first reported a position in Beam Therapeutics in Q1 2021 and has held it in 7 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.